FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1881990858> ?p ?o ?g. }

• W1881990858 abstract "Background Neonates have immature granulopoiesis, which frequently results in neutropenia after sepsis. Neutropaenic septic neonates have a higher mortality than non‐neutropenic septic neonates. Therefore, granulocyte transfusion to septic neutropenic neonates may improve outcomes. Objectives The primary objective was to determine the effect of granulocyte or buffy coat transfusions as adjuncts to antibiotics, after confirmed or suspected sepsis in neutropenic neonates, on all‐cause mortality during hospital stay and neurological outcome at ≥ year of age. Secondary objectives were to determine the effects of granulocyte transfusions on length of hospital stay in survivors to discharge, adverse effects and immunologic outcomes at ≥ year of age. Search methods The Cochrane Central Register of Controlled Trials (The Cochrane Library), MEDLINE, EMBASE and CINAHL, proceedings of the PAS conferences and ongoing trials at clinicaltrials.gov and clinical‐trials.com were searched in July 2011. Selection criteria Studies where neutropenic neonates with suspected or confirmed sepsis were randomised or quasi‐randomised to granulocyte or buffy coat transfusions at any dose or duration, and reporting any outcome of interest were included. Data collection and analysis Relative risk (RR) and risk difference (RD) with 95% confidence intervals using the fixed effects model were reported for dichotomous outcomes. Pre‐specified subgroup analyses were performed. Main results Four trials were eligible for inclusion. Forty‐four infants with sepsis and neutropenia were randomised in three trials to granulocyte transfusions or placebo/no transfusion. In another trial, 35 infants with sepsis and neutropenia on antibiotics were randomised to granulocyte transfusion or IVIG. When granulocyte transfusion was compared with placebo or no transfusion, there was no significant difference in 'all‐cause mortality' (three trials; typical RR 0.89, 95% CI 0.43 to 1.86; typical RD ‐0.05, 95% CI ‐0.31 to 0.21). When granulocyte transfusion was compared with intravenous immunoglobulin (one trial), there was a reduction in 'all‐cause mortality' of borderline statistical significance (RR 0.06, 95% CI 0.00 to 1.04; RD ‐0.34, 95% CI ‐0.60 to ‐0.09; NNT 2.7, 95% CI 1.6 to 9.1). Pulmonary complications were the only adverse effect reported in the trials that used buffy coat transfusions. None of the trials reported on neurological outcome at one year of age or later, length of hospital stay in survivors to discharge or immunological outcome at one year of age or later. Authors' conclusions Currently, there is inconclusive evidence from randomised controlled trials (RCTs) to support or refute the routine use of granulocyte transfusions in neutropenic, septic neonates. Researchers are encouraged to conduct adequately powered multi‐centre trials of granulocyte transfusions in neutropenic septic neonates." @default.
• W1881990858 created "2016-06-24" @default.
• W1881990858 creator A5045743294 @default.
• W1881990858 creator A5056894749 @default.
• W1881990858 date "2011-10-05" @default.
• W1881990858 modified "2023-09-26" @default.
• W1881990858 title "Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia" @default.
• W1881990858 cites W1212948032 @default.
• W1881990858 cites W1488255231 @default.
• W1881990858 cites W1495979563 @default.
• W1881990858 cites W1548457745 @default.
• W1881990858 cites W1552038683 @default.
• W1881990858 cites W1572072402 @default.
• W1881990858 cites W1957004845 @default.
• W1881990858 cites W1969515035 @default.
• W1881990858 cites W1975580849 @default.
• W1881990858 cites W1979192172 @default.
• W1881990858 cites W1981186878 @default.
• W1881990858 cites W1984989435 @default.
• W1881990858 cites W1985081223 @default.
• W1881990858 cites W1991049513 @default.
• W1881990858 cites W1996336860 @default.
• W1881990858 cites W2007542340 @default.
• W1881990858 cites W2013068774 @default.
• W1881990858 cites W2015885078 @default.
• W1881990858 cites W2018770380 @default.
• W1881990858 cites W2020186144 @default.
• W1881990858 cites W2026746053 @default.
• W1881990858 cites W2056135039 @default.
• W1881990858 cites W2057898443 @default.
• W1881990858 cites W2062369978 @default.
• W1881990858 cites W2065100644 @default.
• W1881990858 cites W2067143062 @default.
• W1881990858 cites W2070023397 @default.
• W1881990858 cites W2082569366 @default.
• W1881990858 cites W2091242408 @default.
• W1881990858 cites W2123907472 @default.
• W1881990858 cites W2126275092 @default.
• W1881990858 cites W2140445346 @default.
• W1881990858 cites W2142590198 @default.
• W1881990858 cites W2143239883 @default.
• W1881990858 cites W2169577961 @default.
• W1881990858 cites W2217638208 @default.
• W1881990858 cites W2419627706 @default.
• W1881990858 cites W263475322 @default.
• W1881990858 cites W4241925119 @default.
• W1881990858 cites W4249065032 @default.
• W1881990858 cites W4301710904 @default.
• W1881990858 doi "https://doi.org/10.1002/14651858.cd003956.pub2" @default.
• W1881990858 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7104253" @default.
• W1881990858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21975741" @default.
• W1881990858 hasPublicationYear "2011" @default.
• W1881990858 type Work @default.
• W1881990858 sameAs 1881990858 @default.
• W1881990858 citedByCount "58" @default.
• W1881990858 countsByYear W18819908582012 @default.
• W1881990858 countsByYear W18819908582013 @default.
• W1881990858 countsByYear W18819908582014 @default.
• W1881990858 countsByYear W18819908582015 @default.
• W1881990858 countsByYear W18819908582016 @default.
• W1881990858 countsByYear W18819908582017 @default.
• W1881990858 countsByYear W18819908582018 @default.
• W1881990858 countsByYear W18819908582019 @default.
• W1881990858 countsByYear W18819908582022 @default.
• W1881990858 crossrefType "journal-article" @default.
• W1881990858 hasAuthorship W1881990858A5045743294 @default.
• W1881990858 hasAuthorship W1881990858A5056894749 @default.
• W1881990858 hasBestOaLocation W18819908582 @default.
• W1881990858 hasConcept C126322002 @default.
• W1881990858 hasConcept C142724271 @default.
• W1881990858 hasConcept C177713679 @default.
• W1881990858 hasConcept C187212893 @default.
• W1881990858 hasConcept C197934379 @default.
• W1881990858 hasConcept C204787440 @default.
• W1881990858 hasConcept C27081682 @default.
• W1881990858 hasConcept C2776694085 @default.
• W1881990858 hasConcept C2777063308 @default.
• W1881990858 hasConcept C2778384902 @default.
• W1881990858 hasConcept C2780873365 @default.
• W1881990858 hasConcept C71924100 @default.
• W1881990858 hasConceptScore W1881990858C126322002 @default.
• W1881990858 hasConceptScore W1881990858C142724271 @default.
• W1881990858 hasConceptScore W1881990858C177713679 @default.
• W1881990858 hasConceptScore W1881990858C187212893 @default.
• W1881990858 hasConceptScore W1881990858C197934379 @default.
• W1881990858 hasConceptScore W1881990858C204787440 @default.
• W1881990858 hasConceptScore W1881990858C27081682 @default.
• W1881990858 hasConceptScore W1881990858C2776694085 @default.
• W1881990858 hasConceptScore W1881990858C2777063308 @default.
• W1881990858 hasConceptScore W1881990858C2778384902 @default.
• W1881990858 hasConceptScore W1881990858C2780873365 @default.
• W1881990858 hasConceptScore W1881990858C71924100 @default.
• W1881990858 hasLocation W18819908581 @default.
• W1881990858 hasLocation W18819908582 @default.
• W1881990858 hasLocation W18819908583 @default.
• W1881990858 hasLocation W18819908584 @default.
• W1881990858 hasOpenAccess W1881990858 @default.
• W1881990858 hasPrimaryLocation W18819908581 @default.
• W1881990858 hasRelatedWork W171566421 @default.
• W1881990858 hasRelatedWork W1957712578 @default.

• next